These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7914527)

  • 21. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
    J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract]   [Full Text] [Related]  

  • 22. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The "neuroleptic threshold"--a review of the literature].
    Abraham D; Kissling W; Lauter H
    Psychiatr Prax; 1996 May; 23(3):109-16. PubMed ID: 8710999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuroleptic treatment by the established psychiatrist. A report of experiences].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 1998 Nov; 25(6):284-5. PubMed ID: 9885840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.
    Dickey B; Normand SL; Eisen S; Hermann R; Cleary P; Cortés D; Ware N
    Med Care; 2006 Sep; 44(9):827-34. PubMed ID: 16932134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monotherapy versus polypharmacy for hospitalized psychiatric patients.
    Strous RD; Lerner V
    Am J Psychiatry; 2005 Mar; 162(3):631-2; author reply 632-3. PubMed ID: 15741496
    [No Abstract]   [Full Text] [Related]  

  • 27. Routinely measuring schizophrenia treatment quality--shortcomings with medical records.
    Young AS
    Med Care; 2007 Jan; 45(1):104; author reply 104-5. PubMed ID: 17279029
    [No Abstract]   [Full Text] [Related]  

  • 28. [Trends in multi-high-dose drug therapy for schizophrenia in Japan].
    Miyamoto M
    Seishin Shinkeigaku Zasshi; 2006; 108(6):599-607. PubMed ID: 16910537
    [No Abstract]   [Full Text] [Related]  

  • 29. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
    Hornung WP; Buchkremer G; Redbrake M; Klingberg S
    Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High and low dose thiothixene treatment in chronic schizophrenia.
    Gardos G; Orzack MH; Finn G; Cole JO
    Dis Nerv Syst; 1974 Feb; 35(2):53-8. PubMed ID: 17894041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing the dose of depot neuroleptics in stable schizophrenia.
    Dale R; Longdon M; Seeman MV
    J Psychiatry Neurosci; 1994 Jul; 19(4):278-81. PubMed ID: 7918349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dilemma of early drug intervention in prepsychotic illnesses of adolescence].
    Branik E; Meng H
    Prax Kinderpsychol Kinderpsychiatr; 2003 Dec; 52(10):751-65. PubMed ID: 14699785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Profile of the action of neuroleptics in deficit schizophrenia].
    Vanelle JM
    Encephale; 1996 Jun; 22 Spec No 2():33-9. PubMed ID: 8767040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of schizophrenia].
    Houy-Durand E; Thibaut F
    Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A new study of secondary effects in prescribing practices of neuroleptics].
    Lachaux B; Sechter D; Morasz L; Adouard D
    Encephale; 1997 Apr; 23 Spec No 2():25-34. PubMed ID: 9273304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fluspirilene--safe weekly tranquilizer?].
    Kuhn W; Wöhrle M; Müller T; Welter F
    Nervenarzt; 1997 Jun; 68(6):528. PubMed ID: 9312689
    [No Abstract]   [Full Text] [Related]  

  • 37. [Subjective side effects of neuroleptics].
    de Vries SE
    Ned Tijdschr Geneeskd; 1992 Feb; 136(8):383-4. PubMed ID: 1347158
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of insulin and neuroleptics in treating schizophrenics].
    Maliarov SA; Shpakovich VIa
    Vrach Delo; 1988 Sep; (9):96-7. PubMed ID: 2905550
    [No Abstract]   [Full Text] [Related]  

  • 39. Haase hermeneutics, or, the exegesis of the neuroleptic threshold.
    McEvoy JP; Kamaraju L; Nelson L
    J Clin Psychopharmacol; 1992 Feb; 12(1):64-5. PubMed ID: 1348062
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuroleptics in low doses as tranquilizers?].
    Rüther E; Hippius H
    MMW Munch Med Wochenschr; 1982 Aug; 124(31):683-4. PubMed ID: 6126810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.